Axis 2
Studiedness
- Evidence amount
- 0.81
- Direction balance
- The direction of the study results has not been extracted.
- PMID records loaded
- 6
- Records after title/year deduplication
- 6
entity · release 2026-09-20
Limosilactobacillus reuteri NCIMB 30242
Structured fields rendered from the release dataset. Unknown values retain a reason; price is outside GIS.
Across the corpus
How this organism is actually sold
- Printed CFU per serving
- 2,500,000,000 – 2,500,000,000; median 2,500,000,000. Measured on the 3 of 8 published products carrying it whose latest published label prints a figure for it; the rest print a blend total or no quantity, and earlier label versions in the table below may print other figures. 0 row(s) print a CFU below 1 000 and are excluded as a label or parsing artefact.
- Forms
- Capsule: 8 · counted across the 8 of 8 published products whose label states a form
- Brands carrying it
- gnc-probiotic-solutions (1) · higher-nature (1) · life-extension-florassist (2) · nature-s-way (1) · up4 (1) · the five largest of 7 brands with a published product
- Published product pages
- 8
Products
Published products carrying this organism
| Product | Printed CFU | Printed dose | Cost per day | Form | Gut Index Score |
|---|---|---|---|---|---|
| Nature's Bounty Cardio-Health | 2,500,000,000 | not printed | not observed | Capsule | 84.91 |
| Nature's Way Fortify Digestive & Heart Health | not printed | not printed | not observed | Capsule | 84.03 |
| Life Extension Florassist Florassist Probiotic Heart Health | 2,500,000,000 | not printed | not observed | Capsule | 78.16 |
| NOW Clinical Heart Health Probiotic | 2,500,000,000 | not printed | not observed | Capsule | 73.66 |
| Higher Nature Pro-Woman | not printed | not printed | not observed | Capsule | 73.00 |
| UP4 Heart Health | not printed | not printed | not observed | Capsule | 72.78 |
| GNC Probiotic Solutions Probiotic Solutions Adults 50 Plus 55 Billion CFUs | not printed | not printed | not observed | Capsule | 67.50 |
| Life Extension Florassist Heart Health | not printed | not printed | not observed | Capsule | 66.91 |
Containing labels11
Evidence amount0.81
Direction balanceThe direction of the study results has not been extracted.
Matched PubMed records
6 records (retracted records excluded; 0 retracted records match the query separately). PubMed query
Matched records include trials of multi-ingredient products; this is not a count of trials of this entity alone.
- 2013 · Improvement of gastrointestinal health status in subjects consuming Lactobacillus reuteri NCIMB 30242 capsules: a post-hoc analysis of a randomized controlled trial.
- 2013 · Oral supplementation with probiotic L. reuteri NCIMB 30242 increases mean circulating 25-hydroxyvitamin D: a post hoc analysis of a randomized controlled trial.
- 2012 · Cholesterol lowering and inhibition of sterol absorption by Lactobacillus reuteri NCIMB 30242: a randomized controlled trial.
- 2012 · Evaluation of clinical safety and tolerance of a Lactobacillus reuteri NCIMB 30242 supplement capsule: a randomized control trial.
- 2012 · Evaluation of safety and tolerance of microencapsulated Lactobacillus reuteri NCIMB 30242 in a yogurt formulation: a randomized, placebo-controlled, double-blind study.
- 2012 · Cholesterol-lowering efficacy of a microencapsulated bile salt hydrolase-active Lactobacillus reuteri NCIMB 30242 yoghurt formulation in hypercholesterolaemic adults.
ClinicalTrials.gov
1 interventional studies. ClinicalTrials.gov query
This species has 22 tracked designations; this one appears on 11 labels (median 4).
Species and related strains
Axis 1 · inverted
Containing label versions
Showing 11 of 11 rows, ordered by Gut Index Score descending, then DSLD label ID. Download full CSV · Download full JSON.
| Brand | Product | DSLD | Gut Index Score | Strain named | Per-organism quantity | Potency basis | Versions |
|---|---|---|---|---|---|---|---|
| Nature's Bounty | Cardio-Health | 74379 | 84.91 | true | 2,500,000,000 CFU | through expiry | 3 |
| Nature's Bounty Optimal Solutions | Cardio-Health Probiotics | 74383 | 84.91 | true | 2,500,000,000 CFU | through expiry | 3 |
| Nature's Bounty | Cardio-Health | 76239 | 84.91 | true | 2,500,000,000 CFU | through expiry | 3 |
| Nature's Way | Fortify Digestive & Heart Health | 213643 | 84.03 | true | not printed for this organism | through expiry | 1 |
| Life Extension Florassist | Florassist Probiotic Heart Health | 315568 | 78.16 | true | 2,500,000,000 CFU | at manufacture | 1 |
| HealthyBiom | Lactobacillus reuteri LRC with Vitamin D 5 Billion CFU | 272438 | 73.66 | true | 5,000,000,000 CFU | not stated | 2 |
| NOW | Clinical Heart Health Probiotic | 314104 | 73.66 | true | 2,500,000,000 CFU | not stated | 1 |
| Higher Nature | Pro-Woman | 246058 | 73.00 | true | not printed for this organism | through expiry | 1 |
| UP4 | Heart Health | 176429 | 72.78 | true | not printed for this organism | not stated | 1 |
| GNC Probiotic Solutions | Probiotic Solutions Adults 50 Plus 55 Billion CFUs | 304445 | 67.50 | true | not printed for this organism | through expiry | 1 |
| Life Extension Florassist | Heart Health | 232400 | 66.91 | true | not printed for this organism | at manufacture | 1 |
Axis 3
Measurement integrity
Not a measurement product, so this axis does not apply.
Axis 4
Reddit mention panel
0 observed mentions; no aggregate panel matched this entity.
Elsewhere in this release
Related pages
Findings computed over the whole corpus: Strain naming census · Label designation changes · Strain dose match · Stability literature gaps
Tools: DSLD product check · Unit value calculator
Citation
Cite this page
Ivitskiy, I. (2026). Limosilactobacillus reuteri NCIMB 30242. Gut Registry, release 2026-09-20. Elanvale Ltd. https://gutregistry.com/s/limosilactobacillus-reuteri-ncimb-30242/
The underlying tables are published under CC BY 4.0: this page as CSV · as JSON · full release and data dictionary. Cell-level provenance names the source record and its observation date.
Citable atoms
Release claims
Limosilactobacillus reuteri NCIMB 30242 appears on 11 of 13,330 labels in the NIH DSLD snapshot (Sep 2026), from 9 brands; tied with 25 designations by distinct label count.
11 / 13330 observed label versions · NIH DSLD snapshot Sep 2026 · entity.prevalence · checked 2026-09-20T00:00:00Z · snapshot b7633f7324376 of 11 containing labels in the NIH DSLD snapshot (Sep 2026) print a quantity for Limosilactobacillus reuteri NCIMB 30242 (54.5%); 0 light records have quantities unavailable.
6 / 11 containing labels · NIH DSLD snapshot Sep 2026 · entity.quantity · checked 2026-09-20T00:00:00Z · snapshot b7633f7324376 PubMed records indexed as human randomized controlled trials match the published query (as of 2026-09-15). 6 records (retracted records excluded; 0 retracted records match the query separately).
6 / 6 loaded PMID records · NIH DSLD snapshot Sep 2026 · entity.evidence · checked 2026-09-20T00:00:00Z · snapshot b7633f7324371 interventional studies on ClinicalTrials.gov match the published query.
Published ClinicalTrials.gov query
1 / Not available in this release. interventional registry studies · NIH DSLD snapshot Sep 2026 · entity.registered_trials · checked 2026-09-20T00:00:00Z · snapshot b7633f7324370 of 9 SKUs containing Limosilactobacillus reuteri NCIMB 30242 have a numeric price observation (0.0%) in the release accompanying the NIH DSLD snapshot Sep 2026.
0 / 9 containing SKUs · NIH DSLD snapshot Sep 2026 · entity.price · checked 2026-09-20T00:00:00Z · snapshot b7633f732437